Overview

Evaluation Comparing Two Tau PET Radiotracers, [18F]PI-2620 and [18F]GTP1, in Subjects With Normal Condition or Prodromal to Moderate Alzheimer's Disease

Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This study aims to compare two previously characterized positron emission tomography (PET) radiotracers for brain Tau, [18F]PI-2620 and [18F]GTP1, in subjects with normal cognition or prodromal to moderate Alzheimer's disease (AD).
Phase:
Phase 1
Details
Lead Sponsor:
Genentech, Inc.